Organization
MoonLake Immunotherapeutics
4 clinical trials
Clinical trial
Phase 2, Randomized, Parallel-group, Double-blind, Placebo-controlled Study of Sonelokimab in Patients With Active Moderate to Severe Hidradenitis SuppurativaStatus: Completed, Estimated PCD: 2023-05-09
Clinical trial
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab in Adult Participants With Moderate to Severe Hidradenitis SuppurativaStatus: Recruiting, Estimated PCD: 2025-06-17
Clinical trial
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab in Adult Participants With Moderate to Severe Hidradenitis SuppurativaStatus: Recruiting, Estimated PCD: 2025-06-17
Clinical trial
Phase 2, Randomized, Parallel-group, Double-blind, Placebo-controlled Study of Sonelokimab in Patients With Active Psoriatic ArthritisStatus: Completed, Estimated PCD: 2023-09-05